| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 2.69e-05 | 2 | 104 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 8.03e-05 | 3 | 104 | 2 | GO:1905060 | |
| Domain | Na_Ca_Ex | 8.83e-05 | 3 | 102 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 8.83e-05 | 3 | 102 | 2 | IPR032452 | |
| Domain | Na_Ca_ex_C | 8.83e-05 | 3 | 102 | 2 | PF16494 | |
| Domain | EGF-like_CS | 9.23e-05 | 261 | 102 | 8 | IPR013032 | |
| Domain | Growth_fac_rcpt_ | 2.15e-04 | 156 | 102 | 6 | IPR009030 | |
| Domain | EGF_1 | 5.00e-04 | 255 | 102 | 7 | PS00022 | |
| Domain | EGF_CA | 5.50e-04 | 122 | 102 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.93e-04 | 124 | 102 | 5 | IPR001881 | |
| Domain | EGF_2 | 6.28e-04 | 265 | 102 | 7 | PS01186 | |
| Domain | EGF | 6.37e-04 | 126 | 102 | 5 | PF00008 | |
| Domain | - | 7.20e-04 | 74 | 102 | 4 | 3.40.50.410 | |
| Domain | FN3 | 7.82e-04 | 199 | 102 | 6 | PS50853 | |
| Domain | Calx_beta | 8.09e-04 | 8 | 102 | 2 | SM00237 | |
| Domain | FN3_dom | 1.01e-03 | 209 | 102 | 6 | IPR003961 | |
| Domain | Calx_beta | 1.04e-03 | 9 | 102 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 1.04e-03 | 9 | 102 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.04e-03 | 9 | 102 | 2 | PF01699 | |
| Domain | Calx-beta | 1.04e-03 | 9 | 102 | 2 | PF03160 | |
| Domain | VWFA | 1.06e-03 | 82 | 102 | 4 | PS50234 | |
| Domain | VWA | 1.16e-03 | 84 | 102 | 4 | SM00327 | |
| Domain | EGF_CA | 1.26e-03 | 86 | 102 | 4 | PF07645 | |
| Domain | EGF | 1.83e-03 | 235 | 102 | 6 | SM00181 | |
| Domain | fn3 | 1.95e-03 | 162 | 102 | 5 | PF00041 | |
| Domain | EGF_Ca-bd_CS | 1.97e-03 | 97 | 102 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.12e-03 | 99 | 102 | 4 | PS01187 | |
| Domain | VWF_A | 2.12e-03 | 99 | 102 | 4 | IPR002035 | |
| Domain | ASX_HYDROXYL | 2.20e-03 | 100 | 102 | 4 | PS00010 | |
| Domain | EGF-like_dom | 2.45e-03 | 249 | 102 | 6 | IPR000742 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.72e-03 | 106 | 102 | 4 | IPR000152 | |
| Domain | DnaJ_domain | 2.72e-03 | 51 | 102 | 3 | IPR001623 | |
| Domain | - | FN1 IL20RA CD3D PTPRC HMCN1 CRTAM COL14A1 IGSF9B EXOC2 EPHA5 | 3.36e-03 | 663 | 102 | 10 | 2.60.40.10 |
| Domain | Ald_DH_CS_GLU | 3.37e-03 | 16 | 102 | 2 | IPR029510 | |
| Domain | FN3 | 3.47e-03 | 185 | 102 | 5 | SM00060 | |
| Domain | VWA | 3.55e-03 | 56 | 102 | 3 | PF00092 | |
| Domain | Ald_DH_CS_CYS | 3.81e-03 | 17 | 102 | 2 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.27e-03 | 18 | 102 | 2 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.27e-03 | 18 | 102 | 2 | PS00687 | |
| Domain | - | 4.75e-03 | 19 | 102 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 4.75e-03 | 19 | 102 | 2 | PF00171 | |
| Domain | Ald_DH_C | 4.75e-03 | 19 | 102 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 4.75e-03 | 19 | 102 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 4.75e-03 | 19 | 102 | 2 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 4.75e-03 | 19 | 102 | 2 | IPR015590 | |
| Domain | - | 4.75e-03 | 19 | 102 | 2 | 3.40.309.10 | |
| Domain | Ig-like_fold | FN1 IL20RA CD3D PTPRC HMCN1 CRTAM COL14A1 IGSF9B EXOC2 EPHA5 | 5.22e-03 | 706 | 102 | 10 | IPR013783 |
| Pubmed | T/B lineage choice occurs prior to intrathymic Notch signaling. | 2.60e-08 | 3 | 104 | 3 | 15845899 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | FN1 ANK3 CENPE FNBP4 NEB MMP20 SMC5 DNAJC7 XIRP2 KDM4A DNAI7 ZNF292 | 3.34e-08 | 497 | 104 | 12 | 36774506 |
| Pubmed | ABCC3 MBTPS1 CAND1 SLC26A2 OR9I1 SMC5 EMSY XYLT2 NF1 FAM50A SERPINB3 DBF4 SERPINB4 ASPM DKC1 KDM4A USP3 ZNF292 | 7.76e-08 | 1327 | 104 | 18 | 32694731 | |
| Pubmed | 1.44e-06 | 64 | 104 | 5 | 22261194 | ||
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 1.46e-06 | 28 | 104 | 4 | 35227662 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.98e-06 | 123 | 104 | 6 | 26912792 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CAND1 FN1 CETP RAB22A ALDH8A1 NAPA CUBN NEB DNAJC7 ADH5 FAT1 SERPINB3 APPL1 MVB12B | 2.09e-06 | 1016 | 104 | 14 | 19056867 |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 2.23e-06 | 31 | 104 | 4 | 11431694 | |
| Pubmed | CAND1 FN1 ANK3 NAPA LAMB1 DNAJC7 FRMD4B ZNF181 THOP1 ZNF451 APPL1 KDM4A DNAI7 ACBD3 ZNF292 | 6.59e-06 | 1285 | 104 | 15 | 35914814 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15203214 | ||
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 8.86e-06 | 2 | 104 | 2 | 23354406 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22406480 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29941946 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 8.86e-06 | 2 | 104 | 2 | 27668655 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 24625754 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19766701 | ||
| Pubmed | The organization of the human gene NCX1 encoding the sodium-calcium exchanger. | 8.86e-06 | 2 | 104 | 2 | 8921376 | |
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 8.86e-06 | 2 | 104 | 2 | 15504361 | |
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 8.86e-06 | 2 | 104 | 2 | 12702576 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 8.86e-06 | 2 | 104 | 2 | 28935635 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 8.86e-06 | 2 | 104 | 2 | 35022507 | |
| Pubmed | Molecular and functional characterization of the human platelet Na(+) /Ca(2+) exchangers. | 8.86e-06 | 2 | 104 | 2 | 21790537 | |
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 8.86e-06 | 2 | 104 | 2 | 21403642 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25111616 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11267667 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29491058 | ||
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 8.86e-06 | 2 | 104 | 2 | 23168150 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15905513 | ||
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 8.86e-06 | 2 | 104 | 2 | 11863458 | |
| Pubmed | Family-wide Structural Analysis of Human Numb-Associated Protein Kinases. | 8.86e-06 | 2 | 104 | 2 | 26853940 | |
| Pubmed | NCX as a key player in the neuroprotection exerted by ischemic preconditioning and postconditioning. | 8.86e-06 | 2 | 104 | 2 | 23224883 | |
| Pubmed | Human macrophages and monocytes express functional Na(+)/Ca (2+) exchangers 1 and 3. | 8.86e-06 | 2 | 104 | 2 | 23224891 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 8.86e-06 | 2 | 104 | 2 | 22808225 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 8.86e-06 | 2 | 104 | 2 | 14970861 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10653592 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 29112685 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10956412 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20428762 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 35874657 | ||
| Pubmed | 1.15e-05 | 167 | 104 | 6 | 22159717 | ||
| Pubmed | 1.50e-05 | 175 | 104 | 6 | 28071719 | ||
| Pubmed | Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. | 2.65e-05 | 3 | 104 | 2 | 19070595 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 29551690 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 29594857 | ||
| Pubmed | Evaluation of JUN, FN1 and LAMB1 polymorphisms in pterygium in a Chinese Han population. | 2.65e-05 | 3 | 104 | 2 | 35445627 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24117969 | ||
| Pubmed | Identification and characterization of two novel tetratricopeptide repeat-containing genes. | 2.65e-05 | 3 | 104 | 2 | 8836031 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 21382638 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9828132 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 22451727 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 7724531 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24898082 | ||
| Pubmed | Immunohistochemical localization of extracellular matrix proteins in developing lung tissues. | 2.65e-05 | 3 | 104 | 2 | 17334455 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 26057585 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 30149392 | ||
| Pubmed | A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma. | 2.65e-05 | 3 | 104 | 2 | 21126757 | |
| Pubmed | The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. | 2.65e-05 | 3 | 104 | 2 | 12794186 | |
| Pubmed | Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. | 2.65e-05 | 3 | 104 | 2 | 30324228 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 34930901 | ||
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 2.65e-05 | 3 | 104 | 2 | 34127021 | |
| Pubmed | Sodium-calcium exchange in intracellular calcium handling of human airway smooth muscle. | 2.65e-05 | 3 | 104 | 2 | 21858195 | |
| Pubmed | Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). | 2.65e-05 | 3 | 104 | 2 | 24635038 | |
| Pubmed | Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms. | 2.65e-05 | 3 | 104 | 2 | 23224887 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 23224890 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 23224882 | ||
| Pubmed | Heparin enhances serpin inhibition of the cysteine protease cathepsin L. | 2.65e-05 | 3 | 104 | 2 | 19959474 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28715492 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18474427 | ||
| Pubmed | Uteroglobin suppresses SCCA gene expression associated with allergic asthma. | 2.65e-05 | 3 | 104 | 2 | 15677460 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17317768 | ||
| Pubmed | CAND1 CENPE IARS1 DOCK10 NAPA DNAJC7 ADAM10 NF1 PTPRC ATP8A1 WDR11 EXOC2 ACBD3 | 4.67e-05 | 1168 | 104 | 13 | 19946888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 FN1 IARS1 AAK1 DOCK10 NOL10 NF1 WDR11 SERPINB3 SERPINB4 ASPM DKC1 EXOC2 USP3 | 5.15e-05 | 1353 | 104 | 14 | 29467282 |
| Pubmed | Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. | 5.29e-05 | 4 | 104 | 2 | 15557343 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 29274751 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 23985323 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 16549498 | ||
| Pubmed | Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein. | 5.29e-05 | 4 | 104 | 2 | 11024059 | |
| Pubmed | Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. | 5.29e-05 | 4 | 104 | 2 | 12949073 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 21576355 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 12581871 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 6.42e-05 | 26 | 104 | 3 | 34189436 | |
| Pubmed | 8.06e-05 | 28 | 104 | 3 | 18067320 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 18523268 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 12354787 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 30187863 | ||
| Pubmed | The p66Shc knocked out mice are short lived under natural condition. | 8.80e-05 | 5 | 104 | 2 | 22081964 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 11163197 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 9751722 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 23563688 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.12e-04 | 774 | 104 | 10 | 15302935 | |
| Pubmed | 1.21e-04 | 32 | 104 | 3 | 17270348 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 10358768 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 12808103 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 16615129 | ||
| Pubmed | Differential dynamics of cullin deneddylation via COP9 signalosome subunit 5 interaction. | 1.32e-04 | 6 | 104 | 2 | 36423380 | |
| Pubmed | Sodium/calcium exchanger expression in the mouse and rat olfactory systems. | 1.32e-04 | 6 | 104 | 2 | 17311327 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.32e-04 | 6 | 104 | 2 | 16236823 | |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 15060148 | ||
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 20874775 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBTPS1 CAND1 ANK3 FNBP4 AAK1 NAPA THOP1 WDR11 FAM120C ASMTL RALGPS1 IGSF9B STK38L USP3 | 1.42e-04 | 1489 | 104 | 14 | 28611215 |
| Cytoband | 19q13.11 | 1.50e-04 | 45 | 104 | 3 | 19q13.11 | |
| Cytoband | 18q21.3 | 2.76e-04 | 11 | 104 | 2 | 18q21.3 | |
| Cytoband | 16q24 | 6.76e-04 | 17 | 104 | 2 | 16q24 | |
| Cytoband | 2q34 | 1.85e-03 | 28 | 104 | 2 | 2q34 | |
| Cytoband | 9q33.3 | 3.21e-03 | 37 | 104 | 2 | 9q33.3 | |
| GeneFamily | Fibronectin type III domain containing | 4.42e-04 | 160 | 72 | 5 | 555 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 4.28e-06 | 166 | 103 | 7 | M5354 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN | 1.45e-05 | 200 | 103 | 7 | M6601 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 1.45e-05 | 200 | 103 | 7 | M9923 | |
| Coexpression | GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP | 1.45e-05 | 200 | 103 | 7 | M4402 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 1.45e-05 | 200 | 103 | 7 | M6938 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 2.08e-05 | 14 | 103 | 3 | M48002 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CUL2 CAND1 BMP2K CENPE SMC5 ADAM10 TRAK1 PIKFYVE FAT1 DBF4 ZNF451 ACBD3 ZNF292 | 3.12e-05 | 856 | 103 | 13 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL2 CENPE IARS1 DOCK10 DNAJC7 FBXL3 WDR11 DBF4 ASPM APPL1 FYB1 | 5.51e-05 | 656 | 103 | 11 | M18979 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 8.71e-05 | 183 | 103 | 6 | M2993 | |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 1.10e-04 | 191 | 103 | 6 | M8011 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 1.30e-04 | 197 | 103 | 6 | M9916 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN | 1.34e-04 | 198 | 103 | 6 | M4554 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.34e-04 | 198 | 103 | 6 | M8624 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN | 1.38e-04 | 199 | 103 | 6 | M8259 | |
| Coexpression | GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.42e-04 | 200 | 103 | 6 | M294 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP | 1.42e-04 | 200 | 103 | 6 | M9390 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 1.42e-04 | 200 | 103 | 6 | M8959 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 1.42e-04 | 200 | 103 | 6 | M4538 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.42e-04 | 200 | 103 | 6 | M6618 | |
| Coexpression | GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN | 1.42e-04 | 200 | 103 | 6 | M9074 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP | 1.42e-04 | 200 | 103 | 6 | M4488 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 1.42e-04 | 200 | 103 | 6 | M7441 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 1.85e-04 | 210 | 103 | 6 | MM958 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-07 | 175 | 104 | 7 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 184 | 104 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 184 | 104 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-07 | 184 | 104 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-07 | 191 | 104 | 7 | baa70781633a3fe5bf987f9d8dff3884f5167e7f | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.46e-07 | 192 | 104 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-07 | 196 | 104 | 7 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 198 | 104 | 7 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 198 | 104 | 7 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.56e-07 | 200 | 104 | 7 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.25e-06 | 162 | 104 | 6 | adf545cf9357556e2ce7affed01c2f6a24b0581d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.68e-06 | 167 | 104 | 6 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-06 | 167 | 104 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.98e-06 | 170 | 104 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 173 | 104 | 6 | 4e9b6c71030ae0d63d54e7255e4a10b25970fcc4 | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 174 | 104 | 6 | 54166a0faf748cccb6406c2c268e1e6e21caf6d0 | |
| ToppCell | facs-Heart-LV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 174 | 104 | 6 | dc8a238ec1d954bec0f8eb67c04a61734c96f5b5 | |
| ToppCell | facs-Heart-LV-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 175 | 104 | 6 | 5d106ef542b97f97aeb19179e3f72963ead1e82a | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | 12d5c6be6cfbf733e3cb02780606b3725eda7d2b | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | e0769ad06f92423a3cb6c78a61da3ba5bd9b4eae | |
| ToppCell | droplet-Skin-nan-18m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 178 | 104 | 6 | 11c2ce093b7538518c8d4497dc5b0b4da22bf1a8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-06 | 183 | 104 | 6 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-06 | 183 | 104 | 6 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-06 | 183 | 104 | 6 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 4.69e-06 | 184 | 104 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-06 | 185 | 104 | 6 | 326c8b6ea0e9140616d7b867db1385b980dc3678 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.15e-06 | 187 | 104 | 6 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-06 | 189 | 104 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.47e-06 | 189 | 104 | 6 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.47e-06 | 189 | 104 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-06 | 190 | 104 | 6 | 788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19 | |
| ToppCell | control-Lymphoid-CTL|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.81e-06 | 191 | 104 | 6 | 8df23473e24cfa51c09986102ddd391ed0f0b9cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-06 | 191 | 104 | 6 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.81e-06 | 191 | 104 | 6 | 88cb6f828407845918c946f8cee5f940cb81800a | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.81e-06 | 191 | 104 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-06 | 191 | 104 | 6 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.99e-06 | 192 | 104 | 6 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-06 | 192 | 104 | 6 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-CTL|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.99e-06 | 192 | 104 | 6 | ab2c3d829f5cbf4eb386babcfdf851222a2a88e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-06 | 192 | 104 | 6 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.99e-06 | 192 | 104 | 6 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.17e-06 | 193 | 104 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 6.17e-06 | 193 | 104 | 6 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 6.17e-06 | 193 | 104 | 6 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 193 | 104 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 193 | 104 | 6 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 193 | 104 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-06 | 194 | 104 | 6 | 9344556b375fd9267652cdca57b2cbd50a878a1e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.35e-06 | 194 | 104 | 6 | 68e9ad254fe94e2f59cf5c2b2ea3e1245cb85104 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.54e-06 | 195 | 104 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.54e-06 | 195 | 104 | 6 | a7c70284ac47dcc6f47ee2805b76b14edfa1c0b9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.54e-06 | 195 | 104 | 6 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 195 | 104 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.54e-06 | 195 | 104 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.74e-06 | 196 | 104 | 6 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 196 | 104 | 6 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.74e-06 | 196 | 104 | 6 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 196 | 104 | 6 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | PSB-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.74e-06 | 196 | 104 | 6 | 7b5c2a4cdea9a944f83bfc2c493d3076c3daaeaa | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.74e-06 | 196 | 104 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.74e-06 | 196 | 104 | 6 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.94e-06 | 197 | 104 | 6 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-06 | 197 | 104 | 6 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 6.94e-06 | 197 | 104 | 6 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-06 | 197 | 104 | 6 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.14e-06 | 198 | 104 | 6 | 41ead3d3733b79e3e45648d5ce1909e617c35ed7 | |
| ToppCell | Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.14e-06 | 198 | 104 | 6 | 8517386a2f0d14c7d5fc6283e4e16b94d7c5732a | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 7.14e-06 | 198 | 104 | 6 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | PSB-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.35e-06 | 199 | 104 | 6 | eada9bcac5c113561b806bb800cd53c6bb78e16a | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.56e-06 | 200 | 104 | 6 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.56e-06 | 200 | 104 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.56e-06 | 200 | 104 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.56e-06 | 200 | 104 | 6 | 41a206350eff2a196ccc1a36a9636a87c74f6962 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.56e-06 | 200 | 104 | 6 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-05 | 123 | 104 | 5 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.55e-05 | 148 | 104 | 5 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.55e-05 | 148 | 104 | 5 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.72e-05 | 150 | 104 | 5 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-05 | 151 | 104 | 5 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-05 | 151 | 104 | 5 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 2.99e-05 | 153 | 104 | 5 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 153 | 104 | 5 | ce7a23c687e9e7d83d244046de19c854caded09b | |
| ToppCell | RV-17._Lymphocyte|World / Chamber and Cluster_Paper | 3.18e-05 | 155 | 104 | 5 | 189276a3b400b2202e6681e23732e6452bfe704e | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 156 | 104 | 5 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 156 | 104 | 5 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.28e-05 | 156 | 104 | 5 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 160 | 104 | 5 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | Frontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.70e-05 | 160 | 104 | 5 | 70ffbe61cfd729519b23569a43d929b117ab8d5e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 161 | 104 | 5 | 52556b89808e551540f33a13f57417a6696c2438 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 161 | 104 | 5 | 54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-05 | 161 | 104 | 5 | 242891be849a4398fe8bea44875ae1ba57950944 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.92e-05 | 162 | 104 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.04e-05 | 163 | 104 | 5 | b89f586b444f90047c8ce407f53847fd1ee7cca3 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.04e-05 | 163 | 104 | 5 | cbe9b4c4b2e42e9f92a57ed66758af93434db5bb | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.16e-05 | 164 | 104 | 5 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.45e-06 | 197 | 104 | 8 | 3723_DN | |
| Disease | Malignant neoplasm of breast | FN1 CUBN DLL1 ADAM10 EMSY CLASRP SLC8A3 NF1 PTPRC BTK APPL1 DNAH9 | 3.08e-04 | 1074 | 101 | 12 | C0006142 |
| Disease | status epilepticus (biomarker_via_orthology) | 3.94e-04 | 100 | 101 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 5.46e-04 | 109 | 101 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 5.46e-04 | 109 | 101 | 4 | C0000786 | |
| Disease | Miscarriage | 5.46e-04 | 109 | 101 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 5.46e-04 | 109 | 101 | 4 | C0000822 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.03e-03 | 14 | 101 | 2 | DOID:627 (is_implicated_in) | |
| Disease | Autosomal recessive primary microcephaly | 1.18e-03 | 15 | 101 | 2 | cv:C3711387 | |
| Disease | testosterone measurement | ANK3 CENPE FNBP4 MLYCD ADH5 FHAD1 THOP1 NF1 HMCN1 WDR11 CRTAM USP3 | 1.38e-03 | 1275 | 101 | 12 | EFO_0004908 |
| Disease | platelet crit | 1.58e-03 | 952 | 101 | 10 | EFO_0007985 | |
| Disease | Grand Mal Status Epilepticus | 1.59e-03 | 67 | 101 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 1.59e-03 | 67 | 101 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 1.59e-03 | 67 | 101 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 1.59e-03 | 67 | 101 | 3 | C0751523 | |
| Disease | Petit mal status | 1.59e-03 | 67 | 101 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 1.59e-03 | 67 | 101 | 3 | C0393734 | |
| Disease | Status Epilepticus | 1.66e-03 | 68 | 101 | 3 | C0038220 | |
| Disease | Omenn Syndrome | 1.91e-03 | 19 | 101 | 2 | C2700553 | |
| Disease | Severe Combined Immunodeficiency | 2.12e-03 | 20 | 101 | 2 | C0085110 | |
| Disease | Glioblastoma | 2.55e-03 | 79 | 101 | 3 | C0017636 | |
| Disease | Primary microcephaly | 2.56e-03 | 22 | 101 | 2 | C0431350 | |
| Disease | Giant Cell Glioblastoma | 3.03e-03 | 84 | 101 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDSYDFFTEIKTITV | 471 | Q9H2A2 | |
| TDIYKDKESTVQVHY | 76 | P04234 | |
| EEDIVTTVQASYSKK | 381 | P11597 | |
| KYYSEVDSDKVIIIT | 331 | Q5JRM2 | |
| NAVEDEIKKYTTLSY | 211 | Q2M2I8 | |
| VSTSELKKVVALYDY | 211 | Q06187 | |
| FSEYTVVADISVAKI | 146 | P11766 | |
| FKVETSNKVLDYDTS | 86 | O14672 | |
| YFEKDQETSYTIIKS | 506 | P54756 | |
| LEASTFEVLVTEKYE | 1781 | Q7Z2Y8 | |
| EYALAEYTEVKTVTI | 491 | P47895 | |
| KEVDIYTVKTEELSF | 276 | Q9NR22 | |
| SSTKVDIKETYEVEA | 251 | Q9BSQ5 | |
| ETYVAAVKKAISEDS | 131 | Q6ZUJ8 | |
| VVEEEIKKYTTLSYR | 216 | Q9NSY1 | |
| VSKLVFDFVEYEKDT | 331 | Q9UBU7 | |
| VSKYEKTTSAVYDVE | 3326 | Q8IZT6 | |
| TVIYDRLAETSKYKE | 576 | Q9Y2Q0 | |
| KVVVTEVKEEDAFYS | 346 | Q9UKX7 | |
| AIIVYDITKEETFST | 81 | Q9UL26 | |
| SKSYDAVVFDVLKVT | 36 | Q5JS13 | |
| AVERVKEYSKTETEA | 1256 | O15438 | |
| KSLEEDKVVSVFYTV | 266 | Q8NGQ6 | |
| KFTSKEYSVELSETV | 1666 | Q14517 | |
| EVTYSFVKITEKISQ | 276 | Q9Y5G7 | |
| DYVESYSVIEKLSRK | 201 | P21941 | |
| LTLKVEFSSTVVEYE | 41 | Q14703 | |
| VSEFYEETKVKFSEL | 141 | O95671 | |
| NDKVKYEVTEDVYTS | 156 | Q9UKG1 | |
| YEVTEDVYTSRKKQH | 161 | Q9UKG1 | |
| KSDVYKHFITEVDSV | 31 | P11801 | |
| ETEEKNKITAAIFYS | 276 | O95822 | |
| ETVSKIVDSVYYDVL | 4041 | Q5CZC0 | |
| VSKVKEYQVETIVDT | 76 | Q86VP6 | |
| DDIYATETLSKYDTV | 296 | Q9BRR8 | |
| TEVQVFKKYYAEVET | 316 | Q96KP1 | |
| YIKTTAVEIDYDSLK | 561 | O15117 | |
| IDEETYEEIYKSTKR | 66 | P62310 | |
| YSDSTEVKFEELKNV | 456 | O75164 | |
| SGEAEYIEKVVYTVK | 1666 | P07942 | |
| YIEKVVYTVKQSAED | 1671 | P07942 | |
| LFSTYVASHKIEKEE | 171 | Q9H3P7 | |
| YTKVTYSQEDVDKLL | 736 | P0C869 | |
| EVVTFEILSDDYSKI | 96 | Q9BSC4 | |
| SDTKDIKEETYRVET | 1051 | Q76FK4 | |
| KTVIEYEYDVRTTDI | 396 | Q9UHF4 | |
| TIKSLAEIEKEYEYS | 281 | Q9H7P6 | |
| AEVTVKDYTEDYIQT | 5001 | Q96RW7 | |
| YTITVSDDKVIELKF | 3066 | O60494 | |
| YVTEEVTSSEDKRKT | 1026 | Q9Y2I7 | |
| YIESISFLKDKTTVE | 141 | Q9Y2L6 | |
| SDYEIESKYKDVIIA | 241 | B1AJZ9 | |
| DFAKYLTETEDTVKT | 336 | Q96BY6 | |
| YSDSVSTKEVKVIVL | 101 | O95727 | |
| QYVSFKVDSSKESAE | 111 | Q9UKT7 | |
| DTKYQSVYVISEEKD | 701 | O00548 | |
| LEYNVSVYTVKDDKE | 1241 | P02751 | |
| ATKYEVSVYALKDTL | 1876 | P02751 | |
| SEYKISVYTKLQEIE | 981 | Q05707 | |
| QEKIKSEEIEITFSY | 191 | Q14320 | |
| EFKEVKAFITSVLDY | 2306 | A8TX70 | |
| VVIKAVSEYVSSIKD | 356 | Q9NX05 | |
| TSFITVFKYIDDKDV | 416 | Q13617 | |
| KEYTSAVTELVKDDV | 271 | Q6TDU7 | |
| SIEDEKVTYSEISKV | 3011 | Q12955 | |
| EEESYFSTVKIIYTV | 121 | Q02643 | |
| EAVRDYEKVYQTEKT | 346 | Q99615 | |
| EKTIEKDYIDYIQTS | 296 | Q9H819 | |
| EEYETQSSAEAKFVK | 126 | Q7Z4H3 | |
| TVYVKSVSCSDEDEK | 186 | Q7Z589 | |
| EKAIDYTTKIYAVSI | 1301 | Q6ZMW3 | |
| KSETVLDSIDKSVIY | 201 | Q9NYC9 | |
| VVAKDIADTYKVETD | 106 | Q3SXM5 | |
| YVDYSESAKKEVVAE | 416 | O60832 | |
| KTADEFVKESLNYVT | 246 | P37058 | |
| EISATKATVEYQKEV | 2481 | Q02224 | |
| VYVITVDVFDKSSTK | 376 | Q5VU65 | |
| VDVFDKSSTKVYISD | 381 | Q5VU65 | |
| TYKYDTEKEDVVSVV | 461 | O60882 | |
| IKLETVEKVYEIFTS | 826 | Q86VV8 | |
| ADAVVIVFSITDYKS | 111 | Q9BPW5 | |
| KKDTLTEEETQFYIS | 181 | Q9Y2H1 | |
| FVVNTDIYSKEKTIS | 271 | Q8N3X1 | |
| TFEVYLYVTIKDEKV | 181 | Q587J7 | |
| TDEITVYYKAKSEGT | 1006 | P41252 | |
| VDSYTESVKEYDSIS | 256 | P54920 | |
| DAIKKFYQTSVESVD | 121 | P29508 | |
| TYEDSTVAKVEKAAE | 166 | Q8N2M8 | |
| ASQLKTETITYEEKE | 231 | Q9UPV9 | |
| SIKYFSDVEETESKT | 891 | A4UGR9 | |
| SDYISTKKTITEEVI | 1116 | A4UGR9 | |
| SIDYVFVSEKTETSI | 691 | Q9Y4E5 | |
| LVEESEVFESVSAYK | 556 | P50443 | |
| KYSVAKAEAEAEATT | 831 | Q9UPX0 | |
| DVYKSTYADEELVIK | 251 | Q8TD17 | |
| SEVYEKVVDYQEESK | 476 | O60281 | |
| TVLATLVKYTTDEFD | 2621 | P21359 | |
| DAIKKFYQTSVESTD | 121 | P48594 | |
| TLTDEETVVKAKAYI | 491 | Q9Y6I4 | |
| FEVTEDTEKLITAIY | 1166 | Q9BZH6 | |
| QIYTAEEKYVVKTSF | 611 | Q8IY18 | |
| YESTLKALADVEVTY | 61 | P52888 | |
| IEVDLKDTDKSSTYT | 1086 | P08575 | |
| YDITVDTETEVTQYK | 701 | Q9H1B5 | |
| TVIIEKVVKQSYEFS | 101 | Q2M3W8 | |
| KQYVESIDVSSYTEE | 241 | Q5T447 | |
| KLEVIIEESYEFKST | 711 | P32418 | |
| LEVIIEESYEFKTTV | 666 | P57103 | |
| IKDKYTTVLETVDYD | 4676 | P20929 | |
| KTQEAVSELIYKSDF | 5046 | P20929 | |
| AVTDTVSDVKYKEDL | 5326 | P20929 |